ISRCTN96725312已完成3 期
Evaluation of efficacy and clinical benefit of agomelatine (25 to 50 mg/day) over a 6-month treatment period in patients with Major Depressive Disorder.A randomised, double-blind, international multicentre study with parallel groups versus duloxetine (60 mg/day).Twenty-four weeks of treatment.
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 418 人开始时间: 2009年5月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 418
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged between 18 and 65 years, either sex
- •2. Out-patients fulfilling Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for major depressive disorder
排除标准
- •Women of childbearing potential without effective contraception
研究者
相似试验
进行中（未招募）
不适用
Evaluation of efficacy and clinical benefit of agomelatine (25 to 50 mg/day) over a 6-month treatment period in patients with Major Depressive Disorder.A randomised, double-blind, international multicentre study with parallel groups versus duloxetine (60 mg/day).Twenty-four weeks of treatment.MedDRA version: 11.0Level: LLTClassification code 10057840Term: <Manually entered code. Term in E.1.1>Major Depressive DisorderEUCTR2008-004642-92-HUInstitut de Recherches Internationales Servier400
进行中（未招募）
不适用
Evaluation of efficacy and clinical benefit of agomelatine (25 to 50 mg/day) over a 6-month treatment period in patients with Major Depressive Disorder. A randomised, double blind, international multicentre study with parallel groups versus duloxetine (60 mg/day). Twenty-four weeks of treatment. - NDMedDRA version: 9.1Level: LLTClassification code 10057840Term: Major depressionMajor Depressive DisorderEUCTR2008-004642-92-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER400
进行中（未招募）
不适用
Evaluation of efficacy and clinical benefit of agomelatine (25 to 50 mg/day) over a 6-month treatment period in patients with Major Depressive Disorder.A randomised, double-blind, international multicentre study with parallel groups versus duloxetine (60 mg/day).Twenty-four weeks of treatment.Major Depressive DisorderEUCTR2008-004642-92-PTInstitut de Recherches Internationales Servier400
进行中（未招募）
不适用
Evaluation of efficacy and clinical benefit of agomelatine (25 to 50 mg/day) over a 6-month treatment period in patients with Major Depressive Disorder.A randomised, double-blind, international multicentre study with parallel groups versus duloxetine (60 mg/day).Twenty-four weeks of treatment.Major Depressive DisorderEUCTR2008-004642-92-GBInstitut de Recherches Internationales Servier400
尚未招募
2 期
The study of the effect of amaltas with jaggery in constipation in pregnancyCTRI/2023/07/055481Soni Yesha